- Home
- CTVA vs ALC Comparison
CTVA vs ALC Comparison
Compare CTVA & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTVA
- ALC
- Stock Information
- Founded
- CTVA 2018
- ALC 1945
- Country
- CTVA United States
- ALC Switzerland
- Employees
- CTVA N/A
- ALC N/A
- Industry
- CTVA Farming/Seeds/Milling
- ALC Ophthalmic Goods
- Sector
- CTVA Consumer Staples
- ALC Health Care
- Exchange
- CTVA Nasdaq
- ALC Nasdaq
- Market Cap
- CTVA 48.7B
- ALC 40.2B
- IPO Year
- CTVA N/A
- ALC N/A
- Fundamental
- Price
- CTVA $61.38
- ALC $73.89
- Analyst Decision
- CTVA Strong Buy
- ALC Buy
- Analyst Count
- CTVA 17
- ALC 11
- Target Price
- CTVA $78.06
- ALC $91.41
- AVG Volume (30 Days)
- CTVA 4.5M
- ALC 2.2M
- Earning Date
- CTVA 11-04-2025
- ALC 11-11-2025
- Dividend Yield
- CTVA 1.13%
- ALC 0.29%
- EPS Growth
- CTVA 60.76
- ALC N/A
- EPS
- CTVA 2.03
- ALC 2.16
- Revenue
- CTVA $17,177,000,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- CTVA $6.23
- ALC $5.94
- Revenue Next Year
- CTVA $3.38
- ALC $7.71
- P/E Ratio
- CTVA $29.63
- ALC $34.39
- Revenue Growth
- CTVA 1.63
- ALC 4.04
- 52 Week Low
- CTVA $53.40
- ALC $71.55
- 52 Week High
- CTVA $77.41
- ALC $99.20
- Technical
- Relative Strength Index (RSI)
- CTVA 35.31
- ALC 41.09
- Support Level
- CTVA $60.95
- ALC $73.41
- Resistance Level
- CTVA $64.56
- ALC $77.01
- Average True Range (ATR)
- CTVA 0.82
- ALC 0.96
- MACD
- CTVA 0.32
- ALC 0.11
- Stochastic Oscillator
- CTVA 11.91
- ALC 31.17
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.